CytoTronics Launches with $9.25 Million in Seed Funding to Revolutionize Drug Discovery and Phenotypic Screening

Harvard University spinout advances a unique complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform that opens a new dimension in cell-based screening